Label: NAPROXEN SODIUM tablet, film coated

  • NDC Code(s): 58602-819-07, 58602-819-14, 58602-819-19, 58602-819-21, view more
    58602-819-29, 58602-819-38, 58602-819-40
  • Packager: Aurohealth LLC
  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: Abbreviated New Drug Application

Drug Label Information

Updated December 15, 2023

If you are a consumer or patient please visit this version.

  • Naproxen Sodium Tablets, USP 220 mg

    Drug Facts

  • Active ingredient (in each tablet)

    Naproxen sodium USP 220 mg (naproxen 200 mg) (NSAID)*

    *nonsteroidal anti-inflammatory drug

  • Purposes

    Pain reliever/fever reducer

  • Uses

    • temporarily relieves minor aches and pains due to:
    • minor pain of arthritis
    • muscular aches
    • menstrual cramps
    • toothache
    • backache
    • headache
    • the common cold
    • temporarily reduces fever
  • Warnings

    Allergy alert: Naproxen sodium may cause a severe allergic reaction, especially in people allergic to aspirin. Symptoms may include:


    • hives
    • facial swelling
    • asthma (wheezing)
    • shock
    • skin reddening
    • rash
    • blisters

    If an allergic reaction occurs, stop use and seek medical help right away.

    Stomach bleeding warning:
    This product contains an NSAID, which may cause severe stomach bleeding. The chance is higher if you:


    • are age 60 or older
    • have had stomach ulcers or bleeding problems
    • take a blood thinning (anticoagulant) or steroid drug
    • take other drugs containing prescription or nonprescription NSAIDs (aspirin, ibuprofen, naproxen, or others)
    • have 3 or more alcoholic drinks every day while using this product
    • take more or for a longer time than directed

    Heart attack and stroke warning: NSAIDs, except aspirin, increase the risk of heart attack, heart failure, and stroke. These can be fatal. The risk is higher if you use more than directed or for longer than directed.

  • Do not use

    • if you have ever had an allergic reaction to any other pain reliever/fever reducer
    • right before or after heart surgery
  • Ask a doctor before use if

    • the stomach bleeding warning applies to you
    • you have a history of stomach problems, such as heartburn
    • you have high blood pressure, heart disease, liver cirrhosis, kidney disease, asthma, or had a stroke
    • you are taking a diuretic
    • you have problems or serious side effects from taking pain relievers or fever reducers
  • Ask a doctor or pharmacist before use if you are

    • under a doctor's care for any serious condition
    • taking aspirin for heart attack or stroke, because naproxen may decrease this benefit of aspirin
    • taking any other drug
  • When using this product

    • take with food or milk if stomach upset occurs
  • Stop use and ask a doctor if

    • you experience any of the following signs of stomach bleeding:
      • feel faint
      • vomit blood
      • have bloody or black stools
      • have stomach pain that does not get better
    • you have symptoms of heart problems or stroke:
      • chest pain
      • trouble breathing
      • weakness in one part or side of body
      • slurred speech
      • leg swelling
    • pain gets worse or lasts more than 10 days
    • fever gets worse or lasts more than 3 days
    • you have difficulty swallowing
    • it feels like the pill is stuck in your throat
    • redness or swelling is present in the painful area
    • any new symptoms appear
  • If pregnant or breast-feeding,

    ask a health professional before use. It is especially important not to use naproxen sodium at 20 weeks or later in pregnancy unless definitely directed to do so by a doctor because it may cause problems in the unborn child or complications during delivery.

  • Keep out of reach of children.

    In case of overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away.

  • Directions

    • do not take more than directed
    • the smallest effective dose should be used
    • drink a full glass of water with each dose

     Adults and children
     12 years and older
    • take 1 tablet every 8 to 12 hours while symptoms last
    • for the first dose you may take 2 tablets within the first hour
    • do not exceed 2 tablets in any 8 to 12 hour period
    • do not exceed 3 tablets in a 24 hour period
     Children under 12 years
    • ask a doctor
  • Other information

    • each tablet contains: sodium 20 mg
    • store at 20° to 25°C (68° to 77°F). Avoid high humidity and excessive heat above 40°C (104°F).
  • Inactive ingredients

    colloidal silicon dioxide, FD&C blue #2 aluminum lake, hypromellose, magnesium stearate, microcrystalline cellulose, polyethylene glycol, povidone, talc, and titanium dioxide

  • Questions or comments?

    1-855-274-4122

    Distributed by: AUROHEALTH LLC
    279 Princeton-Hightstown Road,
    East Windsor, NJ 08520
    Made in India

    Code: TS/DRUGS/22/2009

  • PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 220 mg (100 Tablets Bottle)

    AUROHEALTH
    NDC 58602-819-21
    Naproxen Sodium Tablets, USP
    220 mg (NSAID)

    • Pain reliever
    • Fever reducer

    STRENGTH TO LAST 12 HOURS
    100
    Tablets


    PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 220 mg (100 Tablet Bottle)

  • PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 220 mg (100 Tablets Carton Label)

    AUROHEALTH
    NDC 58602-819-21
    **Compare to Aleve®

    active ingredient
    Naproxen Sodium Tablets, USP
     220 mg (NSAID)

    • Pain reliever
    • Fever reducer

    STRENGTH TO LAST 12 HOURS
    100 Tablets

    PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 220 mg (100 Tablets Carton Label)

  • INGREDIENTS AND APPEARANCE
    NAPROXEN SODIUM 
    naproxen sodium tablet, film coated
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:58602-819
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    NAPROXEN SODIUM (UNII: 9TN87S3A3C) (NAPROXEN - UNII:57Y76R9ATQ) NAPROXEN SODIUM220 mg
    Inactive Ingredients
    Ingredient NameStrength
    SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
    FD&C BLUE NO. 2 (UNII: L06K8R7DQK)  
    HYPROMELLOSE 2910 (5 MPA.S) (UNII: R75537T0T4)  
    MAGNESIUM STEARATE (UNII: 70097M6I30)  
    MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  
    POLYETHYLENE GLYCOL 8000 (UNII: Q662QK8M3B)  
    POVIDONE K30 (UNII: U725QWY32X)  
    TALC (UNII: 7SEV7J4R1U)  
    TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
    Product Characteristics
    ColorBLUE (light blue) Scoreno score
    ShapeOVALSize12mm
    FlavorImprint Code K;45
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:58602-819-211 in 1 CARTON12/11/2017
    1100 in 1 BOTTLE; Type 0: Not a Combination Product
    2NDC:58602-819-141 in 1 CARTON12/11/2017
    250 in 1 BOTTLE; Type 0: Not a Combination Product
    3NDC:58602-819-071 in 1 CARTON10/25/2021
    324 in 1 BOTTLE; Type 0: Not a Combination Product
    4NDC:58602-819-291 in 1 CARTON10/25/2021
    4150 in 1 BOTTLE; Type 0: Not a Combination Product
    5NDC:58602-819-381 in 1 CARTON10/25/2021
    5300 in 1 BOTTLE; Type 0: Not a Combination Product
    6NDC:58602-819-401 in 1 CARTON10/25/2021
    6500 in 1 BOTTLE; Type 0: Not a Combination Product
    7NDC:58602-819-191 in 1 CARTON09/21/2023
    790 in 1 BOTTLE; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    ANDAANDA20549712/11/2017
    Labeler - Aurohealth LLC (078728447)
    Establishment
    NameAddressID/FEIBusiness Operations
    Aurobindo Pharma Limited650381903ANALYSIS(58602-819) , MANUFACTURE(58602-819)